John P. Scott

Children's Hospital of Wisconsin

Author Statistics

Papers

Citation

H-Index

i-10 index

Research Trends

Author Order

Document Type

Co-Authors

George M. Hoffman

Medical College of Wisconsin

Cheryl A. Hillery

Medical College of Wisconsin

Ronald K. Woods

Children's Hospital of Wisconsin

Michael E. Mitchell

Children's Hospital of Wisconsin

Robert A. Niebler

Children's Hospital of Wisconsin

Julie A. Panepinto

National Institutes of Health

Eckehard A. E. Stuth

Medical College of Wisconsin

Robert R. Montgomery

Children's Hospital of Wisconsin

Pippa Simpson

Medical College of Wisconsin

James S. Tweddell

Cincinnati Children's Hospital Medical Center

Cooperative Institutions

Space Telescope Science Institute

333

Medical College of Wisconsin

172

Children's Hospital of Wisconsin

134

Goddard Space Flight Center

114

Johns Hopkins University

Versiti Blood Center of Wisconsin

Michigan Science Center

University of Arizona

Cincinnati Children's Hospital Medical Center

Max Planck Institute for Astronomy

Author Statistics

Papers

Citation

H-Index

i-10 index

Research Field

Pediatric Resuscitation: Outcome Effects of Location, Intervention, and Duration

Advances in Anesthesiology (2015)

John P. Scott Lindsey Loveland Baptist Richard J. Berens

Cardiopulmonary resuscitation (CPR) is performed in order to restore oxygen delivery and prevent multiorgan system failure and death. Prompt initiation of CPR with appropriate medical or surgical therapy may shorten arrest duration before irreversible organ injury occurs. The brain is most susceptible to irreversible anoxic injury. Survival data suggests that children are more likely than adults to survive and have good neurologic outcomes following cardiac arrest. In this review of pediatric resuscitation, we discuss important predictors of postarrest outcomes as well as advances in resuscitation science focusing on the critical importance of oxygen delivery during periarrest care.

Oxygen delivery

Clinical death

10.1155/2015/517863

Cite

Citations (6)

Long-term hydroxyurea therapy for infants with sickle cell anemia: the HUSOFT extension study

Blood (2005)

Jane S. Hankins Russell E. Ware Zora R. Rogers Lynn Wynn Peter A. Lane

10.1182/blood-2004-12-4973

Cite

Citations (279)

Creating a DDAVP Releasable Pool of Factor VIII: Its Impact on the Gene Therapy of Hemophilia A † 786

Pediatric Research (1998)

Robert R. Montgomery Janet L. Endres Jonathan B. Rosenberg John P. Scott Joan Cox Gill

von Willebrand Disease

10.1203/00006450-199804001-00807

Cite

Citations (0)

Value of culture of biopsy material in diagnosis of viral infections in heart-lung transplant recipients.

PubMed (1990)

T. G. Wreghitt Rosalind L. Smyth John P. Scott T W Higenbottam J. Gray

Value (mathematics)

Source

Cite

Citations (5)

Vitamin B12 deficiency: The great masquerader

Pediatric Blood & Cancer (2013)

Sarah Dobrozsi Veronica H. Flood Julie A. Panepinto John P. Scott Amanda M. Brandow

Vitamin B12 deficiency is rare in children, with nonspecific symptoms including failure to thrive, vomiting, anorexia, and neurologic changes with or without hematologic disturbances. The neuropathy can be severe and irreversible. We report four cases of children with B12 deficiency secondary to adult type pernicious anemia, a presumed transport protein abnormality, and a metabolic defect. All demonstrated neurologic compromise that improved after initiation of B12 therapy. Hematologic manifestations may be preceded by constitutional, gastrointestinal, or neurologic changes, and must raise concern for B12 deficiency. Therapy should be initiated promptly in this setting to prevent irreversible neuropathy. Pediatr Blood Cancer 2014;61:753–755. © 2013 Wiley Periodicals, Inc.

Anorexia

Failure to Thrive

pernicious anemia

Subacute Combined Degeneration

Abnormality

10.1002/pbc.24784

Cite

Citations (26)

Identification of Time-Dependent Risks of Hemodynamic States After Stage 1 Norwood Palliation

The Annals of Thoracic Surgery (2019)

George M. Hoffman John P. Scott Nancy S. Ghanayem Eckehard A. E. Stuth Michael E. Mitchell

10.1016/j.athoracsur.2019.06.063

Cite

Citations (21)

Editorial

European Journal Of Dental Education (1997)

John P. Scott

Editorial board

10.1111/j.1600-0579.1997.tb00001.x

Cite

Citations (0)

Attention Deficit Hyperactivity Disorder in Children With Sickle Cell Disease Referred for an Evaluation

Journal of Pediatric Hematology/Oncology (2017)

Melissa Acquazzino Meghan Miller Matthew P. Myrvik Robert F. Newby John P. Scott

Neuropsychological deficits, including difficulties with attention, are well described in children with sickle cell disease (SCD). Very little is known about attention deficit hyperactivity disorder (ADHD) in children with SCD. The objective of this study was to determine the proportion of ADHD in children with SCD referred for neuropsychological evaluation. This prospective, cross-sectional study included patients (age, 4 to 18 y) with SCD and completion of a neuropsychological evaluation between December 2013 and March 2016. Patients were referred for neuropsychological evaluation because of concern regarding school performance, development, and/or behavior. The diagnosis of ADHD was made by a neuropsychologist on the basis of the diagnostic criteria in the Diagnostic Statistical Manual-Fourth or Fifth Editions. ADHD medication usage rate was obtained by medical record review. Of the 89 patients with SCD referred for neuropsychological evaluation, 25% (95% confidence interval, 16%-35%) met diagnostic criteria for ADHD. Only 21% of the patients with SCD and ADHD were prescribed an ADHD medication. Our study supports routine ADHD screening in children with SCD who have poor school performance or behavioral concerns. Despite the benefits of pharmacologic treatment, the majority of patients with SCD and ADHD did not receive a medication for management of their ADHD.

Neuropsychological Assessment

10.1097/mph.0000000000000847

Cite

Citations (13)

Increased recombinant activated factor VII use and need for surgical reexploration following a switch from aprotinin to epsilon-aminocaproic acid in infant cardiac surgery

Journal of Clinical Anesthesia (2014)

John P. Scott Daniel J. Costigan George M. Hoffman Pippa Simpson Mahua Dasgupta

Aprotinin

Antifibrinolytic

Aminocaproic acid

Activated clotting time

10.1016/j.jclinane.2013.10.015